Fabricant, Peter D. MD, MPH; Seeley, Mark A. MD; Rozell, Joshua C. MD; Fieldston, Evan MD, MBA; Flynn, John M. MD; Wells, Lawrence M. MD; Ganley, Theodore J. MD
From the Hospital for Special Surgery, New York, NY (Dr. Fabricant), the Geisinger Health System, Danville, PA (Dr. Seeley), the Department of Orthopaedic Surgery, University of Pennsylvania, Philadelphia, PA (Dr. Rozell), and the Children’s Hospital of Philadelphia, Philadelphia (Dr. Fieldston, Dr. Flynn, Dr. Wells, and Dr. Ganley).
Dr. Fieldston or an immediate family member has stock or stock options held in Johnson & Johnson and Pfizer. Dr. Flynn or an immediate family member has received royalties from Zimmer Biomet and serves as a board member, owner, officer, or committee member of the American Academy of Orthopaedic Surgeons, the American Board of Orthopaedic Surgery, the Pediatric Orthopaedic Society of North America, and the Scoliosis Research Society. Dr. Wells or an immediate family member serves as a board member, owner, officer, or committee member of the Philadelphia Orthopaedic Society. None of the following authors or any immediate family member has received anything of value from or has stock or stock options held in a commercial company or institution related directly or indirectly to the subject of this article: Dr. Fabricant, Dr. Seeley, Dr. Rozell, and Dr. Ganley.
Correspondence to Dr. Fabricant: [email protected]